|
|
|
| home > white papers > Value-Added Processing and Quality By Design Principles Help Meet High-Quality Demands - West Pharmaceutical Services, Inc. |
|
|
 WHITE PAPERS |
|
West Pharmaceutical Services, Inc.
|
|
Value-Added Processing and Quality By Design Principles Help Meet High-Quality Demands
|
|
The current pharmaceutical market has faced a variety of challenges,
including increasing expectations for quality from end-users and
regulatory agencies driven by concern for patient safety. While
pharmaceutical companies are working to assure that new quality and
compliance paradigms are met, a balance must be achieved between the
reality of managing costs in an effort to provide a product that meets
the requirements of payers along with facilitating profitability in
order to continue adequate business reinvestment.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Zenith Technologies Launches Virtual Manufacturing System Training Service
Zenith Technologies, a world leader in delivering GMP manufacturing
software solutions to the life sciences industry, has launched a new
virtual customised training service to tackle critical gaps in industry
manufacturing software and process training.
More info >> |
|
 |
White Papers |
 |
|
The Role of the CRO in Effective Risk-Based Monitoring
Medpace
The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging trial sponsors to transition from a focused on-site monitoring approach they have traditionally employed toward a risk-based approach that utilizes a combination of centralized and on-site monitoring techniques to ensure patient safety and data quality. The Risk-Based Monitoring (RBM) paradigm has many potential advantages over established monitoring practices including enhanced patient safety and data integrity, more efficient and effective protocol design, reduced costs, and the ability to strategically adjust oversight in keeping with changes in risk level.
More info >> |
|
 |
Industry Events |
 |
BioTrinity 2019
30 April - 1 May 2019, etc.venues 155 Bishopsgate, London EC2M 3YD
BioTrinity 2019 is taking
place from the 30th April – 1stMay at etc.venues 155 Bishopsgatein London. Now in its 13th year, BioTrinity remains the leading Life Sciences Biopartnering
and Investment conference in Europe, and generates unrivalled opportunities for
life science companies, academics, investors, and major pharmaceutical players
to come together to do deals and establish collaborations.
More info >> |
|
|
|
